- 601. ALVAC-hB7.1/Canarypox-hIL-12 Melanoma Vaccine
- (UMLS (NCI) C0796341) =Therapeutic or Preventive Procedure
| - 618. Alveolar Rhabdomyosarcoma
- [A rapidly growing malignant mesenchymal neoplasm. It is characterized by the presence of round cells with myoblastic differentiation and a fibrovascular stroma resembling an alveolar growth pattern. The tumor usually presents in the extremities. ( NCI )] (UMLS (NCI) C0206655) =Neoplastic Process =rhabdomyoblastoma;
|
- 602. ALVAC-hIL-12
- [A vaccine consisting of a replication-defective recombinant canarypox virus (ALVAC) that encodes the gene for human interleukin-12 (hIL-12). Produced mainly by B-cells, IL-12 is an endogenous cytokine that activates natural killer (NK) cells, promotes cytotoxic T lymphocyte (CTL) responses, induces the release of interferon-gamma (IFN-gamma), and may exhibit antitumor and anti-angiogenic effects. Vaccination with canarypox-hIL-12 melanoma vaccine may stimulate the host immune system to mount an immune response against tumor cells, thereby inhibiting tumor growth and/or metastasis. (NCI04) ( NCI )] (UMLS (NCI) C0677735) =Pharmacologic Substance; Immunologic Factor
| - 619. Alveolar Rhabdomyosarcoma of Orbit
- [A malignant mesenchymal neoplasm that arises in the orbit. It is characterized by the presence of round cells with myoblastic differentiation and a fibrovascular stroma. ( NCI )] (UMLS (NCI) C1335126) Alveolar Rhabdomyosarcoma of the Orbit;
Orbit Alveolar Rhabdomyosarcoma;
=Neoplastic Process ;
|
- 603. ALVEOL PNEUMONOPATHY NEC
- (UMLS (ICD9CM) C0155913) =Disease or Syndrome ;
| - 620. Alveolar Sac
- [The terminal dilation of an alveolar duct that gives rise to alveoli in the lung. ( NCI )] (UMLS (NCI) C0225691) =Body Part, Organ, or Organ Component
|
- 604. ALVEOL PNEUMONOPATHY NOS
- (UMLS (ICD9CM) C0155914) =Disease or Syndrome ;
| - 621. Alveolar Soft Part Sarcoma
- [A rare malignant neoplasm characterized by the presence of large epithelioid cells with abundant cytoplasm forming nests and pseudoalveolar structures. The groups of the epithelioid cells are separated by thin-walled sinusoidal spaces. It occurs most often in adolescents and young adults. In adults, the most common sites of involvement are the extremities, and in infants and children the head and neck. It usually presents as a slowly growing mass and it frequently metastasizes to other anatomic sites. The most common sites of metastasis are the lungs, bone, and brain. ( NCI )] (UMLS (NCI) C0206657) =Neoplastic Process =Neoplasms, Muscle Tissue;
Connective Tissue Sarcoma |
- 605. Alveolar border of body of mandible closed fracture
- [ ] (UMLS (ICD9CM) C0159331) =Injury or Poisoning
| - 622. Alveolar Soft Part Sarcoma Metastatic
- [Alveolar soft part sarcoma spreading to another site ( NCI )] (UMLS (NCI) C0855036) Metastatic Alveolar Soft Part Sarcoma;
=Neoplastic Process |
- 606. Alveolar border of body of mandible open fracture
- [ ] (UMLS (ICD9CM) C0159342) =Injury or Poisoning
| - 623. Alveolar Soft Part Sarcoma Nonmetastatic
- [An alveolar soft part sarcoma presently contained in the anatomical site where it initially manifested. ( NCI )] (UMLS (NCI) C0855037) Non-Metastatic Alveolar Soft Part Sarcoma;
Primary Alveolar Soft Part Sarcoma =Neoplastic Process |
- 607. Alveolar Cell Type I
- [A flattened cell of the alveolar epithelium, distinguished by their greatly attenuated cytoplasm and paucity of organelles. ( NCI )] (UMLS (NCI) C0225699) =Cell
| - 624. Alveolar Soft Part Sarcoma Recurrent
- [The reemergence of alveolar soft part sarcoma after a period of remission. ( NCI )] (UMLS (NCI) C0855038) Recurrent Alveolar Soft Part Sarcoma;
Relapsed Alveolar Soft Part Sarcoma =Neoplastic Process |
- 608. Alveolar Cell Type II
- [A pleomorphic cell of the pulmonary alveolar epithelium that secretes surfactant and is distinguished by abundant cytoplasm containing numerous lipid-rich multilamellar bodies. ( NCI )] (UMLS (NCI) C0225700) =Cell
| - 625. Alveolar Wall
- (UMLS (NCI) C0225695) =Body Part, Organ, or Organ Component
|
- 609. Alveolar Childhood Rhabdomyosarcoma
- [An aggressive malignant mesenchymal neoplasm occurring in children. It is characterized by the presence of round cells with myoblastic differentiation, and a fibrovascular stroma resembling an alveolar growth pattern. ( NCI )] (UMLS (NCI) C0279613) =Neoplastic Process
| - 626. Alveolitis
- (UMLS (NCI) C0549493) =Disease or Syndrome ;
|
- 610. Alveolar Duct
- [The respiratory passage distal to the respiratory bronchiole. Alveolar sacs and alveoli arise from the alveolar duct. ( NCI )] (UMLS (NCI) C0391892) =Body Part, Organ, or Organ Component ;
| - 627. ALVEOLITIS OF JAW
- [A condition sometimes occurring after tooth extraction, particularly after traumatic extraction, resulting in a dry appearance of the exposed bone in the socket, due to disintegration or loss of the blood clot. It is basically a focal osteomyelitis without suppuration and is accompanied by severe pain (alveolalgia) and foul odor. (Dorland, 28th ed) ( MSH )] (UMLS (ICD9CM) C0013240) =Disease or Syndrome =Mouth Diseases;
|
- 611. alveolar epithelium
- [Epithelia of lung alveoli. The layer of cells covering the lining of the tiny air sacs at the end of the bronchioles. ( NCI )] (UMLS (CSP) C0225694) =Tissue
| - 628. ALVEOLOPLASTY
- [Surgical preparation of the alveolar ridges, commonly for the reception of dentures. ( NCI )] (UMLS (ICD9CM) C0002393) =Therapeutic or Preventive Procedure
|
- 612. alveolar macrophage
- [round, granular, mononuclear phagocytes found in the alveoli of the lungs that ingest small inhaled particles resulting in degradation and presentation of the antigen to immunocompetent cells. ( CSP )] (UMLS (CSP) C0085236) =Cell =Histiocyte;
Body System, Pulmonary | - 629. ALVEOLUS BIOPSY
- [ ] (UMLS (ICD9CM) C0176407) =Diagnostic Procedure
|
- 613. ALVEOLAR MANDB HYPOPLSIA
- [ ] (UMLS (ICD9CM) C0375350) =Anatomical Abnormality ;
| - 630. Alveus
- (UMLS (NCI) C0228247) =Body Part, Organ, or Organ Component
|
- 614. ALVEOLAR MANDIB HYPRPLAS
- [ ] (UMLS (ICD9CM) C0375348) =Anatomical Abnormality ;
| - 631. Alvimopan
- [A synthetic trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine with peripherally selective opioid mu receptor antagonist activity. Alvimopan is a selective and competitive antagonist at mu-opioid receptors, found in myenteric and submucosal neurons and the immune cells of the lamina propria in the human gut. Upon administration, this agent binds to mu-opioid receptors in the gut, thereby reversing opioid-related disturbances in gut motility. Alvimopan is approximately three to nine times more potent than naloxone. ( NCI )] (UMLS (NCI) C1508750) =Organic Chemical; Pharmacologic Substance
|
- 615. ALVEOLAR MAXIL HYPOPLSIA
- [ ] (UMLS (ICD9CM) C0375349) =Anatomical Abnormality ;
| - 632. Always
- [Always send an acknowledgement. ( HL7V3.0 )] (UMLS (HL7) C1549493) =Idea or Concept =Accept/application acknowledgment conditions;
AcknowledgementCondition |
- 616. ALVEOLAR MAXIL HYPRPLSIA
- [ ] (UMLS (ICD9CM) C0375347) =Anatomical Abnormality ;
| - 633. Always. All MFA segments (whether denoting errors or not) must be returned via the application-level acknowledgment message
- (UMLS (HL7) C1549601) =Idea or Concept =Response level;
|
- 617. Alveolar Pattern
- (UMLS (NCI) C1332240) =Finding ;
| - 634. Alzheimer Center /Dementia Center/Dementia Special Care Unit
- [A freestanding facility or special care unit of a long term care facility focusing on patient care of individuals diagnosed with dementia or Alzheimer's Disease or their related diseases. Six elements of the facility/unit set it apart from other (the rest of the) facilities(y): Admission of residents with dementia (including those with Alzheimer's disease); Staff who are specially selected, trained, and supervised; Activities that are specifically designed for the cognitively impaired; A marketing of a special care unit in brochures; A high level of family involvement; and A physical environment designed to keep residents safe and segregated from other populations. ( HL7V3.0 )] (UMLS (HL7) C1552480) =Manufactured Object; Health Care Related Organization =Nursing and Custodial Care Facilities;
|
home
